The US Food and Drug Administration (FDA) Friday widened the approval for Pfizer's Sutent to treat patients with a rare type of pancreatic cancer.
The US Food and Drug Administration (FDA) Friday widened the approval for Pfizer's Sutent to treat patients with a rare type of pancreatic cancer.